anticipation of zuma-7 results
Published 4 years ago • 132 plays • Length 6:45Download video MP4
Download video MP3
Similar videos
-
1:39
updates on zuma-7: clinical and patient-reported outcomes in elderly patients with r/r lbcl
-
1:15
primary overall survival analysis of the zuma-7 trial
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
2:55
updates from zuma-7: axi-cel for r/r dlbcl
-
1:07
dr. winter discusses the zuma-7 trial in dlbcl
-
7:42
susana - a promise i can't keep (extended mix) [susa records]
-
1:53
latest updates in car-t therapy for follicular lymphoma
-
45:26
quantum mitochondrial magic group call 1
-
3:24
jason westin, md, on the phase iii zuma-7 primary os analysis
-
1:08
zuma-7: overall survival benefit of axi-cel over soc in second-line lbcl
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
4:59
zuma-7: axi-cel is superior to standard of care across common prognostic subgroups in r/r lbcl
-
4:44
zuma-7 subgroup analysis: axi-cel vs soc in elderly patients with r/r lbcl
-
3:49
frederick locke on axi-cel and zuma-7
-
2:12
car-t therapy in second-line for nhl: zuma-7, transform & belinda
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
3:54
zuma-2: outcomes of r/r mcl patients who progressed within 24 months of diagnosis
-
1:17
the impact of car-t therapy in the second-line setting in lymphoma
-
3:16
zuma-12: a phase 2 study of axi-cel as first-line therapy in patients with high-risk large b-cel...
-
0:57
dr. jacobson on the benefit of axi-cel in relapsed/refractory follicular lymphoma
-
2:17
zuma-12: axicabtagene ciloleucel as a first-line therapy in patients with high-risk lbcl
-
1:26
dr. miklos on the results of the zuma-2 trial in mcl